Last updated today
The Applied Genetic Technologies Corporation is a publicly traded (NASDAQ: AGTC) biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida. The company focuses on ophthalmologic genetic diseases. The company's technologies are aimed at products that might have the potential to treat achromatopsia, X-linked retinoschisis, X-linked retinitis pigmentosa, and age-related macular degeneration.
Last updated today
Coming soon.
No recent security news.
More security reports
Cybersecurity & Risk Management Library
The ultimate guide to attack surface and third-party risk management – actionable advice for security teams, managers, and executives.
Breaches
Security research and global news about data breaches.
Explore resources
Third-party risk management
Articles, news, and research on third-party risk management.
Explore resources
Attack Surface Management
Articles, news, and research on attack surface management.
Explore resources
Cybersecurity
Articles, news, and research on cybersecurity.
Explore resources
Leader in Third Party & Supplier Risk Management Software
See how UpGuard shapes up against other platforms in the market.
"This is some text inside of a div block."
Free instant security score
How secure is your organization?
Request a free cybersecurity report to discover key risks on your website, email, network, and brand.
- Instant insights you can act on immediately
- Hundreds of risk factors including email security, SSL, DNS health, open ports and common vulnerabilities
Want a full vendor security report for this company?
Start your free trial and unlock real-time insights to identify and assess vendor risks.